Guidelines on the management of acute myeloid leukaemia in adults

This publication has 158 references indexed in Scilit:

• Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
  Blood, 2006
• Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
  Blood, 2004
• Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients
  European Journal Of Cancer, 2004
• Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group
  Blood, 2003
• Guidelines on the use of colony‐stimulating factors in haematological malignancies
  British Journal of Haematology, 2003
• A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial
  British Journal of Haematology, 1999
• Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials
  British Journal of Haematology, 1997
• Teratogenic effects in a case of maternal treatment for acute myelocytic leukaemia—neonatal and infantile course
  European Journal of Pediatrics, 1994
• Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly?
  Annals of Hematology, 1993
• PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL
  The Lancet, 1986